Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | CRBN | Q96SW2 | 3/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.33 |
| ▸ | PNP | P00491 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
| ▸ | SLC28A1 | O00337 | 1/20 | 0.32 |
| ▸ | SLC28A2 | O43868 | 1/20 | 0.32 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.32 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 0.32 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5916345 | 0.81 | ENPP1 (0.37) | DUT | |
| SCHEMBL5683256 | 0.79 | LMNA (0.35) | DUTALDH1A1LMNACRBNPOLB | |
| SCHEMBL5604080 | 0.77 | PKM (0.40) | DUTALDH1A1LMNACRBNPKM | |
| SCHEMBL11389897 | 0.67 | CRBN (0.46) | DUTALDH1A1LMNACRBNPKM | |
| SCHEMBL23171170 | 0.65 | POLB (0.44) | DUTALDH1A1LMNACRBNPOLB | |
| SCHEMBL7926412 | 0.65 | PKM (0.40) | DUTALDH1A1LMNACRBNPKM | |
| SCHEMBL10196375 | 0.64 | PKM (0.46) | DUTALDH1A1LMNAPKM | |
| SCHEMBL2181554 | 0.63 | CRBN (0.54) | DUTALDH1A1LMNACRBNPKM | |
| SCHEMBL9019445 | 0.63 | CRBN (0.44) | DUTALDH1A1LMNACRBNDDB1 | |
| SCHEMBL14237174 | 0.63 | POLB (0.45) | DUTALDH1A1LMNACRBNPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10245262-B2 | Immunological reagents and uses therefor | THE UNIVERSITY OF QUEENSLAND (AU) | 2019-04-02 | — | — | US | claimed |
| US-20170209442-A1 | IMMUNOLOGICAL REAGENTS AND USES THEREFOR | MONASH UNIVERSITY (AU) | 2017-07-27 | — | — | US | claimed |
| US-20230028742-A1 | COMPOSITIONS AND USES THEREOF | UNIV MELBOURNE (AU) | 2023-01-26 | — | — | US | disclosed |
| US-10245262-B2 | Immunological reagents and uses therefor | THE UNIVERSITY OF QUEENSLAND (AU) | 2019-04-02 | — | — | US | disclosed |
| US-20170209442-A1 | IMMUNOLOGICAL REAGENTS AND USES THEREFOR | MONASH UNIVERSITY (AU) | 2017-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10245262-B2 | Immunological reagents and uses therefor | CD81, MRGPRX2, MRGPRX1 | DUT 3138/4885ALDH1A1 999/4885LMNA 3983/4885 |
| US-20170209442-A1 | IMMUNOLOGICAL REAGENTS AND USES THEREFOR | CD81, MRGPRX2, MRGPRX1 | DUT 3138/4885ALDH1A1 999/4885LMNA 3983/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.